Public health watch: Evolution of COVID-19 treatment in US hospitals

“The home run of this paper is really in the figures built from the UC CORDS database,” study co-author Jonathan Watanabe, PharmD, professor of clinical pharmacy at the University of California, Irvine, said. “You can clearly see how usage of certain medicines grew or declined over the course of the pandemic and how those movements were tied to evidence-based decisions being made by UC healthcare providers in real time. You can monitor the evolution in how we treat our sickest patients.”